RT Journal Article
SR Electronic
T1 Simulated resections and RNS placement can optimize post-operative seizure outcomes when guided by fast ripple networks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.26.24304802
DO 10.1101/2024.03.26.24304802
A1 Weiss, Shennan Aibel
A1 Sperling, Michael R.
A1 Engel, Jerome
A1 Liu, Anli
A1 Fried, Itzhak
A1 Wu, Chengyuan
A1 Doyle, Werner
A1 Mikell, Charles
A1 Mofakham, Sima
A1 Salamon, Noriko
A1 Sim, Myung Shin
A1 Bragin, Anatol
A1 Staba, Richard
YR 2024
UL http://medrxiv.org/content/early/2024/06/29/2024.03.26.24304802.abstract
AB In medication-resistant epilepsy, the goal of epilepsy surgery is to make a patient seizure free with a resection/ablation that is as small as possible to minimize morbidity. The standard of care in planning the margins of epilepsy surgery involves electroclinical delineation of the seizure onset zone (SOZ) and incorporation of neuroimaging findings from MRI, PET, SPECT, and MEG modalities. Resecting cortical tissue generating high-frequency oscillations (HFOs) has been investigated as a more efficacious alternative to targeting the SOZ. In this study, we used a support vector machine (SVM), with four distinct fast ripple (FR: 350-600 Hz on oscillations, 200-600 Hz on spikes) metrics as factors. These metrics included the FR resection ratio (RR), a spatial FR network measure, and two temporal FR network measures. The SVM was trained by the value of these four factors with respect to the actual resection boundaries and actual seizure free labels of 18 patients with medically refractory focal epilepsy. Leave one out cross-validation of the trained SVM in this training set had an accuracy of 0.78. We next used a simulated iterative virtual resection targeting the FR sites that were highest rate and showed most temporal autonomy. The trained SVM utilized the four virtual FR metrics to predict virtual seizure freedom. In all but one of the nine patients seizure free after surgery, we found that the virtual resections sufficient for virtual seizure freedom were larger in volume (p<0.05). In nine patients who were not seizure free, a larger virtual resection made five virtually seizure free. We also examined 10 medically refractory focal epilepsy patients implanted with the responsive neurostimulator system (RNS) and virtually targeted the RNS stimulation contacts proximal to sites generating FR at highest rates to determine if the simulated value of the stimulated SOZ and stimulated FR metrics would trend toward those patients with a better seizure outcome. Our results suggest: 1) FR measures can accurately predict whether a resection, defined by the standard of care, will result in seizure freedom; 2) utilizing FR alone for planning an efficacious surgery can be associated with larger resections; 3) when FR metrics predict the standard of care resection will fail, amending the boundaries of the planned resection with certain FR generating sites may improve outcome; and 4) more work is required to determine if targeting RNS stimulation contact proximal to FR generating sites will improve seizure outcome.Graphical AbstractCompeting Interest StatementS.A.W. has nothing to disclose, I.F. has nothing to disclose, C.W. Medtronic Inc. (advisory board), Micro Systems Engineering Inc. (advisory board), Neuropace Inc. (consultant), Nevro Corp. (consultant). J.E. has nothing to disclose. R.S. has nothing to disclose. M.R.S has received compensation for speaking at continuing medical education (CME) programs from Medscape, Projects for Knowledge, International Medical Press, and Eisai. He has consulted for Medtronic, Neurelis, and Johnson & Johnson. He has received research support from Eisai, Medtronic, Neurelis, SK Life Science, Takeda, Xenon, Cerevel, UCB Pharma, Janssen, and Engage Pharmaceuticals. He has received royalties from Oxford University Press and Cambridge University Press.Funding StatementThis work was fully supported by the National Institute of Health K23 NS094633, a Junior Investigator Award from the American Epilepsy Society (S.A.W.), R01 NS106957(R.J.S.) and R01 NS033310 (J.E.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of California Los Angeles Institutional Review Board Thomas Jefferson University Institutional Review BoardI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesFRfast ripplefRonSfast ripple on spikefRonOfast ripple on oscillationMImutual informationLElocal efficiencyRNSresponsive neurostimulatorSEEGstereo-EEGiEEGintracranial EEGREMrapid-eye movement sleepSOZseizure onset zone